Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Femtech industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Type trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Femtech Industry Insights
3.1 Industry landscape, 2018 - 2032
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Usage of digital technology to manage women health in developed countries
3.2.1.2 Improving access to women care in remote areas
3.2.1.3 Growing awareness regarding women health and wellness in developing countries
3.2.1.4 Increasing burden of chronic and infectious diseases among the female population
3.2.1.5 Growing investments in femtech industry
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of awareness about femtech products and applications
3.3 Growth potential analysis
3.3.1 By type
3.3.2 By application
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Porter's analysis
3.6 PESTLE analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.1.1 BioWink GmbH
4.1.2 Athena Feminine Technologies
4.1.3 Conceivable Inc
4.2 Competitive dashboard, 2021
4.3 Company matrix analysis, 2021
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Femtech Market, By Type
5.1 Key segment trends
5.2 Products
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Software
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Services
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Femtech Market, By Application
6.1 Key segment trends
6.2 Reproductive health
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Pregnancy and nursing care
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Pelvic & uterine healthcare
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 General healthcare & wellness
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Others
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Femtech Market, By End-use
7.1 Key segment trends
7.2 Direct-to-consumer
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Hospitals
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Fertility clinics
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Surgical centers
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.6 Diagnostic centers
7.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.7 Others
7.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Femtech Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Russia
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
Chapter 9 Company Profiles
9.1 BioWink GmbH
9.2 Athena Feminine Technologies
9.3 Conceivable Inc
9.4 Elvie
9.5 HeraMED
9.6 iSono Health
9.7 Minerva Surgical
9.8 Prelude
9.9 Sera Prognostics
9.10 Sustain Natural
9.11 Totohealth
9.12 Univfy
9.13 Nuvo Cares
